Will ICER still bite a manufacturer's hand if that hand is feeding it?

 

Recent reports suggest that the Institute for Clinical and Economic Review (ICER) is considering offering their services, at a cost, to manufacturers. This is a slippery slope with several challenges.

Learn about some of the challenges and opportunities ICER face by pursuing this new revenue stream.  

To read the full article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.